Terms: = Pancreatic cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234
25 results:
1. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract] [Full Text] [Related]
2. Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study.
Jung D; Shin J; Park J; Shin J; Sung YN; Kim Y; Yoo S; Lee BW; Jang SW; Park IJ; Wood LD; Pack CG; Hruban RH; Hong SM
Mod Pathol; 2023 Mar; 36(3):100082. PubMed ID: 36788099
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering Genetic Alterations of Taiwanese Patients with pancreatic Adenocarcinoma through Targeted Sequencing.
Huang CC; Liu CY; Huang CJ; Hsu YC; Lien HH; Wong JU; Tai FC; Ku WH; Hung CF; Lin JT; Huang CS; Chiang HS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163506
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of GIST That Recurred More Than 30 Years after Surgery and Could Be Resected].
Ohmura Y; Takeda Y; Katsura Y; Shinke G; Kawai K; Yanagawa T; Murakami K; Kagawa Y; Masuzawa T; Takeno A; Hata T; Egawa C; Sudo Y; Yoshimura M; Murata K
Gan To Kagaku Ryoho; 2021 Feb; 48(2):257-259. PubMed ID: 33597374
[TBL] [Abstract] [Full Text] [Related]
5. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met.
Damghani T; Moosavi F; Khoshneviszadeh M; Mortazavi M; Pirhadi S; Kayani Z; Saso L; Edraki N; Firuzi O
Sci Rep; 2021 Feb; 11(1):3644. PubMed ID: 33574356
[TBL] [Abstract] [Full Text] [Related]
6. Kinome Array Profiling of Patient-Derived pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.
Creeden JF; Alganem K; Imami AS; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213062
[TBL] [Abstract] [Full Text] [Related]
7. Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors.
Ohshima K; Fujiya K; Nagashima T; Ohnami S; Hatakeyama K; Urakami K; Naruoka A; Watanabe Y; Moromizato S; Shimoda Y; Ohnami S; Serizawa M; Akiyama Y; Kusuhara M; Mochizuki T; Sugino T; Shiomi A; Tsubosa Y; Uesaka K; Terashima M; Yamaguchi K
Cancer Sci; 2019 Dec; 110(12):3821-3833. PubMed ID: 31553483
[TBL] [Abstract] [Full Text] [Related]
8. Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced pancreatic cancer Patients Treated With Stereotactic Body Radiation Therapy.
Rao AD; Liu Y; von Eyben R; Hsu CC; Hu C; Rosati LM; Parekh A; Ng K; Hacker-Prietz A; Zheng L; Pawlik TM; Laheru DA; Jaffee EM; Weiss MJ; Le DT; Hruban RH; De Jesus-Acosta A; Wolfgang CL; Narang AK; Chang DT; Koong AC; Herman JM
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):486-489. PubMed ID: 29157747
[TBL] [Abstract] [Full Text] [Related]
9. Germline
Jouenne F; Chauvot de Beauchene I; Bollaert E; Avril MF; Caron O; Ingster O; Lecesne A; Benusiglio P; Terrier P; Caumette V; Pissaloux D; de la Fouchardière A; Cabaret O; N'Diaye B; Velghe A; Bougeard G; Mann GJ; Koscielny S; Barrett JH; Harland M; Newton-Bishop J; Gruis N; Van Doorn R; Gauthier-Villars M; Pierron G; Stoppa-Lyonnet D; Coupier I; Guimbaud R; Delnatte C; Scoazec JY; Eggermont AM; Feunteun J; Tchertanov L; Demoulin JB; Frebourg T; Bressac-de Paillerets B
J Med Genet; 2017 Sep; 54(9):607-612. PubMed ID: 28592523
[TBL] [Abstract] [Full Text] [Related]
10. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
[TBL] [Abstract] [Full Text] [Related]
11. HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.
Ghadban T; Dibbern JL; Reeh M; Miro JT; Tsui TY; Wellner U; Izbicki JR; Güngör C; Vashist YK
Apoptosis; 2017 Mar; 22(3):369-380. PubMed ID: 27878398
[TBL] [Abstract] [Full Text] [Related]
12. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
Swalchick W; Shamekh R; Bui MM
Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
[TBL] [Abstract] [Full Text] [Related]
13. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
Pettazzoni P; Viale A; Shah P; Carugo A; Ying H; Wang H; Genovese G; Seth S; Minelli R; Green T; Huang-Hobbs E; Corti D; Sanchez N; Nezi L; Marchesini M; Kapoor A; Yao W; Francesco ME; Petrocchi A; Deem AK; Scott K; Colla S; Mills GB; Fleming JB; Heffernan TP; Jones P; Toniatti C; DePinho RA; Draetta GF
Cancer Res; 2015 Mar; 75(6):1091-101. PubMed ID: 25736685
[TBL] [Abstract] [Full Text] [Related]
14. KIT and pdgfra mutations and the risk of GI stromal tumor recurrence.
Joensuu H; Rutkowski P; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Braconi C; Bordoni A; Magnusson MK; Sufliarsky J; Federico M; Jonasson JG; Hostein I; Bringuier PP; Emile JF
J Clin Oncol; 2015 Feb; 33(6):634-42. PubMed ID: 25605837
[TBL] [Abstract] [Full Text] [Related]
15. Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity.
Szasz AM; Szirtes I; Tihanyi B; Barkaszi B; Baranyai Z; Tihanyi T; Harsanyi L; Timar J; Kulka J
Virchows Arch; 2015 Feb; 466(2):237-41. PubMed ID: 25432630
[TBL] [Abstract] [Full Text] [Related]
16. Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.
Wang Q; Zhao Z; Shang J; Xia W
J Diabetes Res; 2014; 2014():763936. PubMed ID: 25401107
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma.
Wei T; Zhang LN; Lv Y; Ma XY; Zhi L; Liu C; Ma F; Zhang XF
Oncotarget; 2014 Nov; 5(21):10307-17. PubMed ID: 25333264
[TBL] [Abstract] [Full Text] [Related]
18. A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.
Aparicio J; García-Mora C; Martín M; Petriz ML; Feliu J; Sánchez-Santos ME; Ayuso JR; Fuster D; Conill C; Maurel J
PLoS One; 2014; 9(1):e82209. PubMed ID: 24416138
[TBL] [Abstract] [Full Text] [Related]
19. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
[TBL] [Abstract] [Full Text] [Related]
20. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
Giacomini CP; Sun S; Varma S; Shain AH; Giacomini MM; Balagtas J; Sweeney RT; Lai E; Del Vecchio CA; Forster AD; Clarke N; Montgomery KD; Zhu S; Wong AJ; van de Rijn M; West RB; Pollack JR
PLoS Genet; 2013 Apr; 9(4):e1003464. PubMed ID: 23637631
[TBL] [Abstract] [Full Text] [Related]
[Next]
